Kelley Hutcheson, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Plano, TXNPI 1518162650
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (47.3%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Atricure, Inc. at 53.8% of the total. Reporting peaked in 2019 at $4,308 and has fallen 99.5% since, to $20 in 2025.
Across 60 payments — averaging $147.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$5K
- AbbVie$2K
- Medtronic$2K
- Edwards Lifesciences$240
- Boston Scientific$208
- EKOS Corporation$172
- plus $241 from 4 others
Across 10 payments — averaging $21,402 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Atricure, Inc.$214K
What the payments were for
- Speaking & faculty fees$95011%
- Travel & lodging$4,19047%
- Food & beverage$3,71642%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 38 | $4,761 |
| AbbVie | 3 | $1,671 |
| Medtronic | 8 | $1,563 |
| Edwards Lifesciences | 3 | $240 |
| Boston Scientific | 2 | $208 |
| EKOS Corporation | 1 | $172 |
| W. L. Gore & Associates, Inc. | 1 | $157 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $39 |
| Abbott | 1 | $25 |
| Solventum Corporation | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNERGY ABLATION SYSTEM$1,192
- Penditure$1,155
- ISOLATOR SURGICAL ABLATION SYSTEM$1,086
- ATRICLIP LAA EXCLUSION SYSTEM$1,086
- DISSECTOR$1,086
- ATRICURE SYNERGY ABLATION SYSTEM$759
- ATRICURE ATRICLIP LAA EXCLUSION$405
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$313
- EKOSONIC$172
- MITRIS RESILIA Mitral Valve$161
- GORE TAG Thoracic Branch Endoprosthesis$157
- ONYX FRONTIER$142
- GENERAL - THERAPIES$138
- Avalus$129
- COOLRAIL LINEAR PEN$123
How this compares
$8,856 in reported general payments places this provider in the 55th percentile of 424 thoracic surgery (cardiothoracic vascular surgery) providers in Texas.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $7,059 |
Paid to pharmacies, not to this prescriber.
Other thoracic surgery (cardiothoracic vascular surgery) in Plano
- Gary JettPlano$277K
- William BrinkmanPlano$266K
- Katherine HarringtonPlano$182K
- Timothy GeorgePlano$146K
- Gregory MessnerPlano$112K
- Michael MackPlano$97K
- Fred LeePlano$92K
- Robert SmithPlano$55K
- Faraz KerendiAustin$906K
- Robert HebelerDallas$723K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.